Exclusive

Publication

Byline

Location

US Patent Issued to PRIMORIS THERAPEUTICS on Sept. 1 for "Method for isolating and culturing cord blood stem cells expressing GDF-3 at high level, and use of GDF-3" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,065, issued on Sept. 1, was assigned to PRIMORIS THERAPEUTICS Co. Ltd. (Gwangmyeong-si, South Korea). "Method for isolating and culturing c... Read More


US Patent Issued to Institute of Biotechnology, Xinjiang Academy of Animal Science (China-Australia Sheep Research Centre, Xinjiang Academy of Animal Science) on Sept. 1 for "Sheep PDGFD, nucleic acids encoding PDGFD and recombinant lentivirus, host cell and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,066, issued on Sept. 1, was assigned to Institute of Biotechnology, Xinjiang Academy of Animal Science (China-Australia Sheep Research Centr... Read More


US Patent Issued to Jiangsu Hengrui Medicine, SHANGHAI HENGRUI PHARMACEUTICAL, SHANGHAI SHENGDI PHARMACEUTICAL on Sept. 1 for "Human interleukin-2 variant or derivative thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,067, issued on Sept. 1, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang, China), SHANGHAI HENGRUI PHARMACEUTICAL Co. LTD. (Sh... Read More


US Patent Issued to Imusyn on Sept. 1 for "Stabilized MHC I" (German Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,068, issued on Sept. 1, was assigned to Imusyn GmbH & Co. KG (Hannover, Germany). "Stabilized MHC I" was invented by Clemens Schneeweiss (H... Read More


US Patent Issued to Hoffmann-La Roche on Sept. 1 for "Modification of antibody FcRn binding" (German Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,069, issued on Sept. 1, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Modification of antibody FcRn binding" was invented b... Read More


US Patent Issued to Imunopharm Technology, BEIJING YIMIAOYILIAO on Sept. 1 for "Antibody specifically binding to strep-tag II tag and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,070, issued on Sept. 1, was assigned to Imunopharm Technology Co. Ltd. (Beijing) and BEIJING YIMIAOYILIAO Co. LTD (Beijing). "Antibody spec... Read More


US Patent Issued to B-Portal Biologics on Sept. 1 for "Fusion constructs and uses thereof" (New York Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,071, issued on Sept. 1, was assigned to B-Portal Biologics Inc. (New York). "Fusion constructs and uses thereof" was invented by Daniel Cha... Read More


US Patent Issued to Ablynx, Sanofi on Sept. 1 for "Immunoglobulin variable domains" (Belgian Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,072, issued on Sept. 1, was assigned to Ablynx NV (Ghent-Zwijnaarde, Belgium) and Sanofi (Paris). "Immunoglobulin variable domains" was inv... Read More


US Patent Issued to FNCT BIOTECH on Sept. 1 for "Use of M-CSF or G-CSF for diagnosis or treatment of pulmonary fibrosis" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,073, issued on Sept. 1, was assigned to FNCT BIOTECH INC (Seoul, South Korea). "Use of M-CSF or G-CSF for diagnosis or treatment of pulmona... Read More


US Patent Issued to TORAY INDUSTRIES on Sept. 1 for "Medicament for treatment and/or prevention of cancer" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,074, issued on Sept. 1, was assigned to TORAY INDUSTRIES Inc. (Tokyo). "Medicament for treatment and/or prevention of cancer" was invented ... Read More